The objective of this study is evaluating melatonin effects on sleep patterns, symptoms of hyperactivity and attention deficiency in ritalin treated children with attention deficit hyperactivity disorder. forty four children referring to private psychology clinic at the age range of 7-12 who meet the inclusion criteria will divide in to two groups in a double blind permuted block randomized allocation design based on gender blocks. One group taking melatonin (3or6mg based on weight: 3mg in children under 30kg and 6mg in children above 30kg according to Kristiaan and colleagues (KRISTIAAN, HEIJDEN et al. 2007) combined with Ritalin (1mg/kg), and the other group taking placebo combined with Ritalin (1mg/kg). In the first visit, personal and demographic questionnaires, special tests for ADHD (based on diagnostic criteria for DSM-IV) such as ADHD Rating Scale, SDSC (Sleep Disturbance Scale for Children) sleep questionnaire will complete by mothers; and then, anthropometric measurements in standard situation will perform.
ADHD rating scale and SDSC sleep questionnaires will complete by mothers at baseline, and will repeat at 2, 4, and 8 weeks after the treatment. Anthropometric assessments will done at baseline and will repeat 8 weeks after the treatment. At the end of study, the stimulant drug side effects questionnaire will complete by mothers; then, the side effects will compare between the two groups.